1. IMS Institute for Healthcare Informatics. Global outlook for medicines through 2018. 2014. Available at: http://www.imshealth.com/en/thought-leadership/ims-institute/reports/global-outlook-for-medicines-through-2018.
2. Informatic tools and approaches in postmarketing pharmacovigilance used by FDA;Weaver;AAPS J,2008
3. Drug safety. Gaps in the safety net;Couzin;Science,2005
4. Post-marketing surveillance: a UK/European perspective;Gough;Curr Med Res Opin,2005
5. National surveillance of emergency department visits for outpatient adverse drug events;Budnitz;JAMA,2006